Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2005
03/03/2005US20050048534 Expression vector comprising nucleotide sequences coding colon specific polypeptide for use in diagnosis, prevention, imaging and treatment of cell proliferative disorders; immunotherapy and diagnostics
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay
03/03/2005US20050048521 Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands
03/03/2005US20050048520 Nogo receptor homologs
03/03/2005US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders
03/03/2005US20050048513 Apparatus comprising two electrodes and a cyclical electric field generator for use in enhancing binding of biopolymers; genomics, biochemical separation, molecular genetic and nucleic acid analysis
03/03/2005US20050048512 Combinatorial libraries of monomer domains
03/03/2005US20050048508 Trehalose receptor and method for detecting trehalose with the same
03/03/2005US20050048506 Methods for encoding non-biological information on microarrays
03/03/2005US20050048504 Human SGII-related gene variants associated with cancers
03/03/2005US20050048503 Aldose reductase-like gene (ARL) for use in diagnosing large cell lung cancer or hepatocellular carcinoma; immunoassay
03/03/2005US20050048502 Human SACH-related gene variants associated with cancers
03/03/2005US20050048499 Using spectrum analysis of bodily fluids to detect aberrations in enzyme activity and detect genetic disorders
03/03/2005US20050048493 Using multilayered film for high throughput screening of potential drug compounds
03/03/2005US20050048492 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determining cyp46 genotype
03/03/2005US20050048491 Methods and kits for use in selecting approaches to treating cancer
03/03/2005US20050048490 Cell growth, differentiation and death polypeptide (CGDD) for use in diagnosis, prevention and treatment of cell proliferative, developmental, neurological, autoimmune, inflammatory and reproductive disorders
03/03/2005US20050048489 Using mass marker moiety attached via a cleavable linker having at least one amide bond to a mass normalisation moiety as diagnostic tool in protein expression profiling and nucleic acid sorting
03/03/2005US20050048487 Such as thrombin binding aptamer attached by terminal phosphate to amino sepharose via carbodiimide mediated coupling
03/03/2005US20050048485 Novel nucleic acid probe and novel method of assaying nucleic acid using the same
03/03/2005US20050048479 Adenylyl and guanylyl cyclases
03/03/2005US20050048477 Reagents and methods for detection and characterization of protein-protein interactions, nuclear export and localization sequences and inducible gal4p-mediated gene expression in yeast
03/03/2005US20050048474 Process and apparatus for separating and recovering particles from a liquid sample
03/03/2005US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
03/03/2005US20050048465 Method of collecting nasopharyngeal cells and secretions for diagnosis of viral upper respiratory infections and screening for nasopharyngeal cancer
03/03/2005US20050048464 Method of screening candidate compounds for susceptibility to biliary excretion
03/03/2005US20050048462 Using excitatory amino acid as tools in detection as well as evaluation of activated synapsis; screening for compounds which treat epilepsy, neurodegeneration, ischemia, migraines, schizophrenia and/or depression; cognition activators
03/03/2005US20050048077 Compositions, test kits and methods for detecting helicobacter pylori
03/03/2005US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines
03/03/2005US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
03/03/2005US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
03/03/2005US20050048061 Uses of mammalian cytokines and agonists; related reagents
03/03/2005US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
03/03/2005US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits
03/03/2005US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide
03/03/2005US20050048045 Regulation of urokinase receptor expression by phosphoglycerate kinase
03/03/2005US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050047998 Phosphoprotein target for insulin and its antagonists
03/03/2005US20050047996 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers
03/03/2005US20050047973 Fully automated and parameter regulated; simultaneous performance of polymerase chain reaction and microarray based testing in single chamber system; simple construction, low manufacturing cost; reproducibility; preventing contamination
03/03/2005US20050047965 Reproducible collection of solid particles from fluidized beds; accurate monitoring of reactor conditions for efficient adjustment
03/03/2005US20050047964 Automatic analyzer
03/03/2005US20050047476 Coating dry estimating method, coating dry estimating system and recording medium
03/03/2005US20050046758 Method of transcribing biomolecular patterns, method of manufacturing chip boards, and method of manufacturing biochips
03/03/2005US20050046421 Methods for identifying a compound that can bind to membrane-bound receptors
03/03/2005US20050045494 Pulse-type gas concentration measurement system and method thereof
03/03/2005US20050045493 Method and apparatus for detection of chemical vapors
03/03/2005US20050045476 Systems and methods for blood glucose sensing
03/03/2005US20050044972 Accelerating qualification testing for tissue implant components; measuring change in monoclinic phase after steam treatment
03/03/2005US20050044948 System and method for automatically measuring and tracking a feature of material used during a manufacturing process
03/03/2005US20050044928 Odor discriminating apparatus
03/03/2005DE19952911B4 Verfahren und Einrichtung zur in-situ Überwachung von Tonabdichtungen in Abfalldeponien Method and apparatus for in-situ monitoring of Tonabdichtungen in landfills
03/03/2005DE10359449B3 A sensor carrier tube formed from a mixture of vegetable fiber material, starch and/or protein useful for measuring metal or cryolithic melts, especially cast iron, steel, or copper melts
03/03/2005DE10337668A1 Molekulare Sonde und Material zum Nachweis eines Analyts und deren Verwendung And a molecular probe for detecting an analyte material and the use thereof
03/03/2005DE10337368A1 Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids
03/03/2005DE10336760A1 Method for in vivo labeling of defined cell types in a tissue, useful for detecting specific cells and to establish expression profiles, by providing cell-specific expression of fluorescent protein
03/03/2005DE10335856A1 Measurement of mass of fibrous band in spinning plant for textiles, by filtering out desired frequency band from sensor signals, for use in processing signals from other sensors
03/03/2005DE10335611A1 Plaster for obtaining a skin liquid primarily for diagnostic purposes comprises means for vacuum generation, for collection and transfer of the liquid, and for insertion of test strips and/or sensors or their contact elements
03/03/2005DE10332804A1 Biosensor for detection of microorganisms, polynucleotide sequences, peptides, polypeptides, metal ions or organic molecules using auxiliary electrode, reference electrode and at least one working electrode
03/03/2005DE102004036765A1 Maskieren von chemischen Arrays Masking chemical arrays
03/03/2005DE102004031424A1 Mikrochemischer Chip und Verfahren zu dessen Herstellung Microchemical chip and process for its preparation
03/03/2005CA2537263A1 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005CA2536515A1 Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values
03/03/2005CA2536504A1 Heparin binding proteins: sensors for heparin detection
03/03/2005CA2536491A1 Muteins of tear lipocalin
03/03/2005CA2536388A1 Methods and systems for profiling biological systems
03/03/2005CA2536359A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
03/03/2005CA2536328A1 Method of examining colon cancer and colon adenoma
03/03/2005CA2536305A1 Sod-1 epitopes and antibodies
03/03/2005CA2536062A1 Methods for reducing complexity of a sample using small epitope antibodies
03/03/2005CA2535971A1 Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
03/03/2005CA2535969A1 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders
03/03/2005CA2535921A1 Novel rat calcium channel subunits and related probes, cell lines and methods
03/03/2005CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005CA2535754A1 Human autism susceptibility gene and uses thereof
03/03/2005CA2535513A1 Crosslinking within coordination complexes
03/03/2005CA2535510A1 Detecting and profiling molecular complexes
03/03/2005CA2535394A1 Method of constructing a biosensor
03/03/2005CA2531995A1 Methods, kits and antibodies for detecting parathyroid hormone
03/03/2005CA2525810A1 Sensor platform using a horizontally oriented nanotube element
03/03/2005CA2501155A1 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
03/02/2005EP1510959A2 Protein design automation for protein libraries
03/02/2005EP1510943A1 Interaction predicting device
03/02/2005EP1510822A2 Chemiluminescence method using a 1,2-dioxetane derivative, and composition for chemiluminescence comprising it
03/02/2005EP1510821A1 Diagnosis and treatment of mycobacterial infections
03/02/2005EP1510820A1 Method for detecting medically relevant conditions in a solubilized LBC sample
03/02/2005EP1510819A1 Bioassay unit and substrate for bioassay
03/02/2005EP1510818A2 Odor discriminating apparatus
03/02/2005EP1510815A1 Method of nondestructive examination of chromium-containing nickel-based alloy for grain boundary corrosion and examination apparatus
03/02/2005EP1510814A1 Gas sensor, fuel cell system employing it, and automobile
03/02/2005EP1510813A2 Method and apparatus for measuring quenchant properties of coolants
03/02/2005EP1510808A1 Biosensor and method of manufacturing biosensor
03/02/2005EP1510219A1 Method for identifying at least one Aminopeptidase-inhibitor
03/02/2005EP1510211A1 Pharmaceutical composition comprising N-retinyl-N-retinylidene Ethanolamine (A2E), isoforms of A2E or derivatives thereof
03/02/2005EP1510171A1 Analytical device with prediction module and related methods
03/02/2005EP1509774A1 Device for analyzing a test sample and for providing corresponding analysis data
03/02/2005EP1509773A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
03/02/2005EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2)